Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F72TD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,259
Award facts
- Contract value 100% obligated
- $59,259.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $59,259.09 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 4, 2025. This is a firm fixed price, non-set-aside contract supporting federal medical supply requirements. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of medications and medical supplies to military healthcare programs worldwide. Repatha (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in eligible patients.
As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a critical vendor for federal medical procurement across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The company has demonstrated its capability to meet federal procurement requirements through competitive open-market awards, with delivery orders ranging from small transactions to substantial orders exceeding $45,000. This award reflects AmerisourceBergen's ongoing role supporting Defense Health Agency medical supply needs and other government healthcare systems through DLA's flexible pharmaceutical contracting vehicles.
Quick answers
Who was awarded contract SPE2DR26F72TD?
SPE2DR26F72TD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F72TD worth?
The government has obligated $59,259 on SPE2DR26F72TD.
Is contract SPE2DR26F72TD an order under another contract?
Yes. SPE2DR26F72TD is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F72TD competed?
The extent of competition for SPE2DR26F72TD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award